{"title": "Kalisch A., Komplement\u00e4rmedizin in der Therapie der Polyneuropathie", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2006-01-01", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Toggle navigation\nAGSMO aktuell\n\u00dcber uns\nMitgliedschaft\nLeitlinien, Empfehlungen\nPublikationen\nProjekte/Studien\nAGSMO Veranstaltungen\nLogin\nKalisch A., Komplement\u00e4rmedizin in der Therapie der Polyneuropathie\nAGSMO aktuell\nPublikationen\nKongressberichte\n2019 AGSMO\nKalisch A., Komplement\u00e4rmedizin, Polyneuropathie\nKalisch-AGSMO_PNP_Vortrag_14032019.pdf\n(\n702KB\n)\nA.Kalisch, Komplement\u00e4rmedizin in der Therapie der Polyneuropathie\nLiteratur\n\u00dcbersichtsartikel\nSonstige Publikationen\nKongressberichte\n2019 AGSMO\nArends J., Baumann F., K\u00f6rperliche Aktivit\u00e4t, Ern\u00e4hrung und Stoffwechsel\nBeutner K., Rehabilitation: Studie OPTIREHA\nKalisch A., Komplement\u00e4rmedizin, Polyneuropathie\nKn\u00f6tgen, G. Sicht der Pflege: Wie viel hat der \u201eaufgekl\u00e4rte\u201c Patient verstanden?\nK\u00f6nig, V., Verbesserungsm\u00f6glichkeiten an der Schnittstelle Akutklinik/Rehabilitation\nKoeppen S., Neuropathie bei Tumortherapie\nKoeppen,S. Strik, H. Workshop Neurologie\nLink H., Patienten Blut Management - medizinische Onkologie\nLink H., Risiko der Neutropenie und febrilen Neutropenie bei Chemotherapie, FN-Risiko App\nLink, H. et al., a multicentre, non-interventional study with epoetin theta (Eporatio\u00ae) in patients with chemotherapy-induced symptomatic anaemia\nMatzdorff, A. Antikoagulation bei Tumorpatienten\nOverkamp F., Digitalisierung in der Supportivtherapie?\nSchilling,G., Langzeit\u00fcberlebende - Psychoonkologie\nSchmidt,H., Jahn, P., Patientenaufkl\u00e4rung und Implementierung\nS\u00f6ntgerath R., Bewegungsintervention in der P\u00e4diatrie\nSteindorf, K., Krafttraining: Lebensqualit\u00e4t, Fatigue und Schlafprobleme bei Patienten mit Pankreaskarzinom\n2018 DKK Supportivtherapie\n2016\n2012\n2011\n2010\n2009\n2008\n2007\n2006\n2004\n2003\nBuchpublikation online\nSupportivtherapie bei malignen Erkrankungen\n, Herausgeber: H. Link, C. Bokemeyer, P. Feyer [\nMehr\n]\nBisphosphonat-Therapie\nLaufzettel zu \u00dcberweisung / Konsil vor Bisphosphonat-\nTherapie\n[\nMehr\n]", "language": null, "image": null, "pagetype": null, "links": ["#content", "https://www.onkosupport.de/asors/content/", "https://www.onkosupport.de/asors/content/e674/", "https://www.onkosupport.de/asors/content/e4124/", "https://www.onkosupport.de/asors/content/e4125/", "https://www.onkosupport.de/asors/content/e4126/", "https://www.onkosupport.de/asors/content/e4127/", "https://www.onkosupport.de/asors/content/e4131/", "https://www.onkosupport.de/asors/content/e4215/", "https://www.onkosupport.de/asors/content/index_ger.html", "https://www.onkosupport.de/asors/content/e4126/index_ger.html", "https://www.onkosupport.de/asors/content/e4126/e677/index_ger.html", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/index_ger.html", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4585/index_ger.html", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4585/manage?lang=ger&dtpref_sitemap=1", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4585/e4586/Kalisch-AGSMO_PNP_Vortrag_14032019.pdf", "https://www.onkosupport.de/asors/content/e4126/e4484/", "https://www.onkosupport.de/asors/content/e4126/e974/", "https://www.onkosupport.de/asors/content/e4126/e1743/", "https://www.onkosupport.de/asors/content/e4126/e677/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4619/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4583/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4585/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4605/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4607/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4587/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4603/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4590/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4592/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4611/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4617/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4596/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4626/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4621/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4599/", "https://www.onkosupport.de/asors/content/e4126/e677/e4582/e4609/", "https://www.onkosupport.de/asors/content/e4126/e677/e4510/", "https://www.onkosupport.de/asors/content/e4126/e677/e4424/e4486/", "https://www.onkosupport.de/asors/content/e4126/e677/e3676/", "https://www.onkosupport.de/asors/content/e4126/e677/e3625/e3639/", "https://www.onkosupport.de/asors/content/e4126/e677/e3413/e3486/", "https://www.onkosupport.de/asors/content/e4126/e677/e2647/", "https://www.onkosupport.de/asors/content/e4126/e677/e2104/e2105/", "https://www.onkosupport.de/asors/content/e4126/e677/e1394/e1668/", "https://www.onkosupport.de/asors/content/e4126/e677/e1399/e1274/", "https://www.onkosupport.de/asors/content/e4126/e677/e1400/e1272/", "https://www.onkosupport.de/asors/content/e4126/e677/e1402/e1271/", "./../../../e1206", "./../../../e1206", "./../../../e1743/e1861/e1862", "./../../../e1743/e1861/e1862", "https://www.onkosupport.de/asors/content/e674/e440/", "https://www.onkosupport.de/asors/content/e674/e429/", "https://www.onkosupport.de/asors/content/e674/e440/#e4575"]}